What ICH S9 - Nonclinical Evaluation for Anticancer Pharmaceuticals: Timing of Studies, General Toxicology, Genotoxicity and Reproductive Toxicology requires
This regulation requires that nonclinical studies for anticancer pharmaceuticals be conducted in accordance with ICH S9, specifically…
This is a preview. The full record adds the complete summary, 10 workflow steps, 10 schema fields and 5 primary citations. Start a free trial or see pricing.
Pillar: Pharmaceuticals & Life Sciences · Authority: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use · Version: 1.0.0 · Last updated:
Primary source: https://www.ich.org/page/safety-guidelines
SHA-256 integrity: af657658b99ecede301fad4586b4efb030ecaa21fb6fd0c3e3e3de0ec0ededfc
Primary Citations — 5 traced to source
- ICH S9, Section 3 - Timing of Nonclinical Studies
- ICH S9, Section 4 - General Toxicology
+ 3 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/ich-s9-nonclinical-anticancer-pharmaceutical-2010.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/ich-s9-nonclinical-anticancer-pharmaceutical-2010.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/ich-s9-nonclinical-anticancer-pharmaceutical-2010
- Back to registry: Browse all 10,102 compliance nodes